Addition of Avelumab to Best Supportive Care After Firstline Chemo Improves Survival in Advanced Urothelial Cancer

Immunotherapy with avelumab improved survival when given as maintenance therapy in patients whose disease did not progress on platinum-based chemotherapy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news